137 related articles for article (PubMed ID: 46240)
1. Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B-1.
Orange RP
J Immunol; 1975 Jan; 114(1 Pt 1):182-6. PubMed ID: 46240
[TBL] [Abstract][Full Text] [Related]
2. The effect of thiols on immunologic release of slow reacting substance of anaphylaxis. I. Human lung.
Orange RP; Chang PL
J Immunol; 1975 Oct; 115(4):1072-7. PubMed ID: 51872
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE.
Ishizaka T; Ishizaka K; Orange RP; Austen KF
J Immunol; 1971 May; 106(5):1267-73. PubMed ID: 4102404
[No Abstract] [Full Text] [Related]
4. The effect of thiols on the immunologic release of slow reacting substance of anaphylaxis. II. Other in vitro and in vivo models.
Orange RP; Moore EG
J Immunol; 1976 Feb; 116(2):392-7. PubMed ID: 55439
[TBL] [Abstract][Full Text] [Related]
5. Human lung tissue and anaphylaxis. Evidence that cyclic nucleotides modulate the immunologic release of mediators through effects on microtubular assembly.
Kaliner M
J Clin Invest; 1977 Oct; 60(4):951-9. PubMed ID: 197128
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413.
Nishimura N; Ito K; Tomioka H; Yoshida S
Immunopharmacol Immunotoxicol; 1987; 9(4):511-21. PubMed ID: 2449488
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the synthesis and release of slow-reacting substance of anaphylaxis from sensitized monkey lung.
Weichman BM; Hostelley LS; Bostick SP; Muccitelli RM; Krell RD; Gleason JG
J Pharmacol Exp Ther; 1982 May; 221(2):295-302. PubMed ID: 6176708
[TBL] [Abstract][Full Text] [Related]
8. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung.
Ishizaka T; Ishizaka K; Orange RP; Austen KF
J Immunol; 1970 Feb; 104(2):335-43. PubMed ID: 4189671
[No Abstract] [Full Text] [Related]
9. The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.
Platshon LF; Kaliner M
J Clin Invest; 1978 Dec; 62(6):1113-21. PubMed ID: 85634
[TBL] [Abstract][Full Text] [Related]
10. IgE-mediated histamine and SRS-A release from respiratory cells and peripheral blood leukocytes of rhesus monkeys.
Patterson R; Chakrin LW; Suszko IM; Mengel J; Wardell JR
J Lab Clin Med; 1976 Jun; 87(6):1016-24. PubMed ID: 58954
[TBL] [Abstract][Full Text] [Related]
11. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine.
Tauber AI; Kaliner M; Stechschulte DJ; Austen KF
J Immunol; 1973 Jul; 111(1):27-32. PubMed ID: 4123374
[No Abstract] [Full Text] [Related]
12. Modulation of slow-reacting substance of anaphylaxis and histamine release by prostacyclin and thromboxanes [proceedings].
Engineer DM; Jose PJ; Piper PJ; Tippins JR
J Physiol; 1978 Aug; 281():42P. PubMed ID: 81301
[No Abstract] [Full Text] [Related]
13. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
14. Release of slow reacting substance of anaphylaxis from human leukocytes.
Grant JA; Lichtenstein LM
J Immunol; 1974 Mar; 112(3):897-904. PubMed ID: 4130114
[No Abstract] [Full Text] [Related]
15. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
16. Symposium on allergic lung disease. IV. Immunologic mechanisms for release of chemical mediators of anaphylaxis from human lung tissue.
Kaliner M
Can Med Assoc J; 1974 Feb; 110(4):431 passim. PubMed ID: 4134081
[TBL] [Abstract][Full Text] [Related]
17. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
18. [Effect of aspirin and indomethacin on the immunological release of histamine and slow reacting substance of anaphylaxis (SRS-A) from guinea-pig lung tissues (author's transl)].
Kitamura S; Ishihara Y; Izumi T; Kosaka K
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 May; 18(5):317-21. PubMed ID: 6157854
[No Abstract] [Full Text] [Related]
19. Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells.
Ishizaka T; Ishizaka K; Tomioka H
J Immunol; 1972 Feb; 108(2):513-20. PubMed ID: 4114955
[No Abstract] [Full Text] [Related]
20. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
